欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/1113/003
药品名称
Sevikar 40 mg/10 mg
活性成分
amlodipine 10.0 mg
olmesartan medoxomil 40.0 mg
剂型
Film-coated tablet
上市许可持有人
Daiichi Sankyo Europe GmbH München Germany
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Romania (RO)
SEVIKAR 40 mg/10 mg comprimate filmate
Germany (DE)
Sevikar 40 mg/10 mg Filmtabletten
Belgium (BE)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
France (FR)
Spain (ES)
Portugal (PT)
Sevikar
Italy (IT)
Greece (GR)
许可日期
2008/07/30
最近更新日期
2024/08/22
药物ATC编码
C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Fixed combination Art 10b Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
common_outer_sevlabelcarton_clean_aml_ccdsII_201607
Date of last change:2024/09/06
Final PL
|
common_pl_sev_clean_updAUTOIMMHEP_IAIN_202203
Date of last change:2024/09/06
Final SPC
|
common_spc_sev_clean_updAMLoverdose_IAIN_202206_VRE
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase